Figure 4.
GATA2 IHC in adult AML. (A-D) Representative fields of GATA2 IHC in 3 different adult AML cases (3,3′-Diaminobenzidine [DAB] and hematoxylin; original magnification ×400). (E-F) Percent GATA2+ bone marrow blasts in acute leukemia subtypes (AMLs, n = 75; ALLs, n = 26; AULs, and n = 5). (G-H) Correlation between percent GATA2+ blasts and (G) neutropenia (n = 75) and (H) complex cytogenetics (n=74)) in AML. Error bars = SEM; ∗P < .05 and ∗∗∗P < .005.

GATA2 IHC in adult AML. (A-D) Representative fields of GATA2 IHC in 3 different adult AML cases (3,3′-Diaminobenzidine [DAB] and hematoxylin; original magnification ×400). (E-F) Percent GATA2+ bone marrow blasts in acute leukemia subtypes (AMLs, n = 75; ALLs, n = 26; AULs, and n = 5). (G-H) Correlation between percent GATA2+ blasts and (G) neutropenia (n = 75) and (H) complex cytogenetics (n=74)) in AML. Error bars = SEM; ∗P < .05 and ∗∗∗P < .005.

Close Modal

or Create an Account

Close Modal
Close Modal